Search Results

Filter
  • 1-10 of  27 results for ""Oligodeoxyribonucleotides, Antisense""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases.

  • Authors : Bishop KM; Otonomy, 6275 Nancy Ridge Drive, San Diego, 92121, CA, USA. Electronic address: .

Subjects: Central Nervous System Agents/Central Nervous System Agents/Central Nervous System Agents/*therapeutic use ; Central Nervous System Diseases/Central Nervous System Diseases/Central Nervous System Diseases/*drug therapy ; Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/*therapeutic use

  • Source: Neuropharmacology [Neuropharmacology] 2017 Jul 01; Vol. 120, pp. 56-62. Date of Electronic Publication: 2016 Dec 18.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.

  • Authors : Zhang P; Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, PR China.; Yang CL

Subjects: Immunity, Humoral/Immunity, Humoral/Immunity, Humoral/*drug effects ; Myasthenia Gravis, Autoimmune, Experimental/Myasthenia Gravis, Autoimmune, Experimental/Myasthenia Gravis, Autoimmune, Experimental/*drug therapy ; Myasthenia Gravis, Autoimmune, Experimental/Myasthenia Gravis, Autoimmune, Experimental/Myasthenia Gravis, Autoimmune, Experimental/*immunology

  • Source: Molecular immunology [Mol Immunol] 2018 Feb; Vol. 94, pp. 200-208. Date of Electronic Publication: 2018 Jan 12.Publisher: Pergamon Press Country of Publication: England NLM ID: 7905289 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Suppression of HUVEC tissue factor synthesis by antisense oligodeoxynucleotide.

  • Authors : Stephens AC; King's College London, Department of Asthma, Allergy and Respiratory Science, 5th Floor Thomas Guy House, Guy's Hospital, London SE1 9RT, UK. ; Ranlall NF

Subjects: Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*physiology ; Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/*pharmacology ; Thromboplastin/Thromboplastin/Thromboplastin/*biosynthesis

  • Source: Thrombosis research [Thromb Res] 2008; Vol. 122 (1), pp. 99-107. Date of Electronic Publication: 2007 Oct 24.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in K-562 cell line.

  • Authors : Vellón L; Departamento de Genetica, Instituto de Investigaciones Hematológicas Mariano R. Castex, Academia Nacional de Medicina, J.A. Pacheco de Melo 3081, 1425, Buenos Aires, Argentina. ; González-Cid M

Subjects: Apoptosis/Apoptosis/Apoptosis/*drug effects ; Cholesterol/Cholesterol/Cholesterol/*analogs & derivatives ; Idarubicin/Idarubicin/Idarubicin/*pharmacology

  • Source: Leukemia research [Leuk Res] 2002 Jul; Vol. 26 (7), pp. 669-76.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice.

Subjects: Amnesia/Amnesia/Amnesia/*physiopathology ; Avoidance Learning/Avoidance Learning/Avoidance Learning/*drug effects ; Cerebral Ventricles/Cerebral Ventricles/Cerebral Ventricles/*physiology

  • Source: Neuropharmacology [Neuropharmacology] 1999 Mar; Vol. 38 (3), pp. 339-48.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain.

  • Authors : Tremblay M; Unité de recherche en neuroscience, Centre Hospitalier Universitaire du Québec, Canada.; Rouillard C

Subjects: Oligodeoxyribonucleotides, Antisense*/Oligodeoxyribonucleotides, Antisense*/Oligodeoxyribonucleotides, Antisense*/genetics; Prosencephalon/Prosencephalon/Prosencephalon/*physiology ; Receptors, Dopamine D2/Receptors, Dopamine D2/Receptors, Dopamine D2/*physiology

  • Source: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 1998 Jul; Vol. 22 (5), pp. 857-82.Publisher: Pergamon Press Country of Publication: England NLM ID: 8211617 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: the pros and cons.

  • Authors : Zhao G; Department of Cardiovascular Diseases, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, PR China.; Zhao Y

Subjects: Cerebrovascular Disorders/Cerebrovascular Disorders/Cerebrovascular Disorders/*therapy ; Glucosephosphate Dehydrogenase/Glucosephosphate Dehydrogenase/Glucosephosphate Dehydrogenase/*antagonists & inhibitors ; Glucosephosphate Dehydrogenase/Glucosephosphate Dehydrogenase/Glucosephosphate Dehydrogenase/*genetics

  • Source: Neurochemistry international [Neurochem Int] 2012 Jul; Vol. 61 (2), pp. 146-55. Date of Electronic Publication: 2012 May 08.Publisher: Pergamon Press Country of Publication: England NLM ID: 8006959 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy.

Subjects: Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/chemically induced ; Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/complications ; Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/Charcot-Marie-Tooth Disease*/genetics

  • Source: Neuromuscular disorders : NMD [Neuromuscul Disord] 2011 Jan; Vol. 21 (1), pp. 58-67. Date of Electronic Publication: 2010 Oct 14.Publisher: Pergamon Press Country of Publication: England NLM ID: 9111470 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma.

  • Authors : Iyer R; Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences and Central Arkansas VA Medical Center, Little Rock, AR 72205, USA.; Ding L

Subjects: Genes, bcl-2* ; Genes, p53*; Dexamethasone/Dexamethasone/Dexamethasone/*pharmacology

  • Source: Leukemia research [Leuk Res] 2003 Jan; Vol. 27 (1), pp. 73-8.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Adenovirus-mediated G(alpha)(q)-protein antisense transfer in neurons replicates G(alpha)(q) gene knockout strategies.

  • Authors : Abogadie FC; Wellcome Laboratory for Molecular Pharmacology, University College London, UK. ; Bron R

Subjects: Calcium Signaling/Calcium Signaling/Calcium Signaling/*physiology ; Neurons/Neurons/Neurons/*physiology ; Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/Oligodeoxyribonucleotides, Antisense/*pharmacology

  • Source: Neuropharmacology [Neuropharmacology] 2002 Jun; Vol. 42 (7), pp. 950-7.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print Cited Medium: Print

Record details

×
  • 1-10 of  27 results for ""Oligodeoxyribonucleotides, Antisense""